Stay updated on Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Locations section reorganized to include a Colorado entry under a general Locations header; the Colorado Locations subheading was removed, and the revision label updated to v3.3.3 with the HHS Vulnerability Disclosure link removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-18T21:37:12.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added: These publications are automatically filled in from PubMed, a public database of scientific and medical articles, and may or may not be about the study; Revision: v3.3.2. Deleted: These publications come from PubMed, this list is automatically created by ClinicalTrials.gov Identifier (NCT Number), and these articles may or may not be about the study; Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-27T04:09:44.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Removed a site-wide notice about government funding and NIH Clinical Center operations. No study data or requirements were changed.
    Difference
    0.3%
    Check dated 2025-11-19T22:00:37.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Results data for the study were added and posted, including primary and secondary outcomes. The Study Record Dates show the results submission and posting.
    Difference
    0.4%
    Check dated 2025-10-29T06:19:10.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a current operating status link, and - updated the revision version from v3.1.0 to v3.2.0. No other substantive content changes were detected.
    Difference
    2%
    Check dated 2025-10-07T20:38:46.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Updated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new software version.
    Difference
    0.0%
    Check dated 2025-09-30T00:15:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.